Skip to main content

TGA grants third provisional approval to COVID-19 vaccine: Janssen

The TGA granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen, making it the third COVID-19 vaccine to receive regulatory approval in Australia.

Related content

Help us improve the Therapeutic Goods Administration site